We’re Up 118% on Allarity (ALLR) Today.
Since adding Allarity (ALLR) to the Watch List at $0.70, we are up 194%, and that ain't bad - for exactly 4 months and...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
Latest article
National Investment Bankers Conference
Companies Scheduled to Present
Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150...
Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.
This Week's GSA Announcement Marks Sekur’s 4th Major Milestone.
GSA Approval is akin to an electrician just starting out in the business, and being told...
Halted Stocks Watch List
We are following Companies which have been suspended by the SEC and will update news related to them here. In near real time.
To...
